Hypertensive COVID-19 patients presented elevated levels of serum urea nitrogen, serum creatinine, lactate dehydrogenase, creatine kinase, and NT-proBNP and markedly reduced eGFR at admission. This evidence concerns the gene NPPB and COVID-19.